Forskolin, by elevating intracellular cAMP levels, activates protein kinase A (PKA), which can lead to the phosphorylation of multiple proteins within the cell, potentially affecting the regulatory mechanisms of IST1. Phorbol 12-myristate 13-acetate (PMA), a known activator of protein kinase C (PKC), also influences the phosphorylation state of cellular proteins, which could indirectly alter IST1 function. Ionomycin, through its capacity to increase intracellular calcium levels, may activate calcium-dependent signaling pathways, intersecting with IST1's regulation or activity. LY294002, a specific inhibitor of PI3K, and U0126, a MEK inhibitor, both serve to disrupt upstream signaling, which can have downstream consequences on the phosphorylation and activation states of multiple proteins, including IST1. SB203580 and PD98059, which inhibit p38 MAPK and MEK respectively, could similarly alter the signaling milieu and potentially modulate IST1 activity.
Rapamycin, despite being primarily known as an mTOR inhibitor, has broader implications for cellular growth and signaling that could affect IST1. Staurosporine, although a non-selective kinase inhibitor, may impact a variety of signaling pathways within the cell, offering potential modulation of IST1 activity through its wide-ranging effects on kinase activity. Additionally, compounds such as 2-Deoxy-D-glucose challenge the cellular energy status by interfering with glycolysis, which can lead to the activation of energy-sensing pathways that may impinge on IST1's role within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate downstream proteins that may interact with or regulate IST1. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium-dependent signaling pathways that may intersect with IST1 regulatory mechanisms. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
This cAMP analog can permeate cell membranes and mimic the effect of cAMP, potentially affecting IST1 activity by altering PKA signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
An inhibitor of PI3K, LY294002 can alter AKT signaling, which may have downstream effects on IST1 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
As an inhibitor of MEK, U0126 can affect ERK pathway signaling, potentially influencing IST1's involvement in cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor can modify p38 pathway activity, which might intersect with IST1 regulation or function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
By inhibiting MEK, PD98059 can affect the ERK pathway and potentially modulate IST1 activity indirectly. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
While primarily an mTOR inhibitor, Rapamycin can have broad effects on cell growth and signaling that might affect IST1. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor with broad specificity, Staurosporine can alter multiple signaling pathways, thereby potentially influencing IST1 activity. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
This glucose analog can interfere with glycolysis and cellular energy levels, which may indirectly affect signaling pathways involving IST1. | ||||||